AKRO: Akero Therapeutics Inc

46.73 USD 0.21 (0.45%)

Sector: Healthcare Base: US Dollar Profit currency: US Dollar

AKRO exchange rate has changed by -0.45% for today. During the day, the instrument was traded at a low of 46.02 and at a high of 47.34.

Follow Akero Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.

Full Screen Chart

AKRO News

13:40 Has Akero Therapeutics (AKRO) Outpaced Other Medical Stocks This Year?
13:55 Does Akero Therapeutics (AKRO) Have the Potential to Rally 59.14% as Wall Street Analysts Expect?
15:13 RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study
21:45 Akero Therapeutics: Reversing My Contrarian Buy Rating To A Contrarian Sell Rating (AKRO)
15:11 Allogene's Q2 Loss Narrower Than Expected, Pipeline in Focus
22:54 Akero Therapeutics CEO Cheng sells $1.46 million in stock
22:51 Akero Therapeutics COO Young sells $597k in shares
00:45 Akero therapeutics director Henderson sells $142k in shares
13:40 Are Medical Stocks Lagging Akero Therapeutics (AKRO) This Year?
14:54 Akero Therapeutics stock strengthened as Morgan Stanley reiterates Overweight rating
10:22 Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2025 Commentary
18:36 Akero Therapeutics stock initiated with Buy rating at TD Cowen on MASH potential
18:35 Akero Therapeutics stock initiated with Buy rating at TD Cowen on MASH treatment potential
15:30 This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Akero Therapeutics (NASDAQ:AKRO), Apartment Inv & Mgmt (NYSE:AIV)
10:20 Janus Henderson Global Life Sciences Fund Q2 2025 Commentary (Mutual Fund:JAGLX)
12:46 Altimmune Gears Up to Report Q2 Earnings: Here's What to Expect
16:10 Amarin Gears Up to Report Q2 Earnings: Here's What to Expect
15:42 Incyte Gears Up to Report Q2 Earnings: Is a Beat in the Cards?
14:45 VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales
09:46 Altimmune: Potential Tough Road Ahead Amid Fierce Competition (Rating Downgrade) (ALT)
14:53 Exelixis' Q2 Earnings: Will Cabometyx Sales Drive Growth?
13:38 Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect
15:28 RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure
14:39 FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo

Daily Range

46.02 47.34

Year Range

21.34 58.40

Previous Close: 46.94
Open: 47.01

Bid: 46.73
Ask: 47.03

Low: 46.02
High: 47.34

Volume: 1.002 K

Daily Change: -0.45%
Month Change: -3.49%

6 Months Change: -2.65%
Year Change: 73.14%

31 August, Sunday